Double-blind, randomized, placebo-controlled, clinical trial. Patients with diabetic neuropathy will be randomly assigned to treatment with either TENS or TENS sham three times a week during 90 days. Clinical determinations are: pain, levesls of TNF-alpha, IL-6 and RPC-us
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
20
Sessions of 30 minutes of TENS will be applied three times a week during 90 days
University of Guadalajara
Guadalajara, Jalisco, Mexico
Pain perception
Evaluation of neuropathic pain evaluated with VAS
Time frame: Change from Baseline Pain perception at 90 days
Tumoral Necrosis Factor Alpha
Serum levels of TNF-alpha
Time frame: Change from Baseline serum levels of TNF-alpha at 90 days
Interleukin-6
Serum levels of IL-6
Time frame: Change from Baseline serum levels of IL-6 at 90 days
C Reactive Protein ultra-sensible
Serum levels of CRP-us
Time frame: Change from Baseline serum levels of CRP-us at 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.